Cited by 777Alzheimer's disease research and treatmentsAntioxidant Activity and Oxidative StressDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Open access

Praticò, Domenico, Uryu, Kunihiro, Leight, Susan, Trojanoswki, John Q., Lee, Virginia M.-Y.·2001·The Journal of Neuroscience

DOI 10.1523/jneurosci.21-12-04183.2001PMC PMC6762743

Open this paper in CoChat — free account Open PDF

Abstract

Oxidative stress is a key feature in the Alzheimer's disease (AD) brain and manifests as lipid peroxidation (LPO). Isoprostanes (iPs) are specific and sensitive markers of in vivo LPO. To determine whether amyloid beta (Abeta) deposition in vivo is associated with increased LPO, we examined iP levels in a transgenic mouse model (Tg2576) of AD amyloidosis. Urine, plasma, and brain tissues were collected from Tg2576 and littermate wild-type (WT) animals at different time points starting at 4 months of age and continuing until 18 months of age. Levels of urinary 8,12-iso-iPF(2alpha)-VI were higher in Tg2576 than in WT animals as early as 8 months of age and remained this high for the rest of the study. A similar pattern was observed for plasma levels of 8,12-iso-iPF(2alpha)-VI. Homogenates from the cerebral cortex and hippocampus of Tg2576 mice had higher levels of 8,12-iso-iPF(2alpha)-VI than those from WT mice starting at 8 months of age. In contrast, a surge of Abeta 1-40 and 1-42 levels as well as Abeta deposits in Tg2576 mouse brains occurred later, at 12 months of age. A direct correlation was observed between brain 8,12-iso-iPF(2alpha)-VI and Abeta 1-40 and 1-42. Because LPO precedes amyloid plaque formation in Tg2576 mice, this suggests that brain oxidative damage contributes to AD pathogenesis before Abeta accumulation in the AD brain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.21-12-04183.2001

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
The measurement and mechanism of lipid peroxidation in biological systems
Gutteridge, J. M. C., & Halliwell, B. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,297
Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease
Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 4×
“Indeed, the recent demonstration of rare Ab plaques as well as scant amounts of formic acid-extractable Ab in 8-month-old Tg2576 mouse brains prompts cautious interpretation of our data with respect to whether LPO precedes or is linked to the initial stages of AD-like amyloidosis in Tg2576 mice ( Kawarabayashi et al.,…”
BackgroundInfluential
Antioxidants, Oxidative Stress, and Degenerative Neurological Disorders
Floyd, R. A. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-140.x · Cited by 828
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 789
Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain
Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7013 · Cited by 676
APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress
Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547
Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins
Hsiao, K., Borchelt, D., Olson, K., Johannsdottir, R., Kitt, C. A., Yunis, W. S., Xu, S., Eckman, C., Younkin, S. G., Price, D., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90107-8 · Cited by 527
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide
Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406

Show all 24 references

Research works printed but not linked: 1

Pappolla, 1998, Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease., Am J Pathol, 152, 871

Sorted by citations

Items 201–300 of 776

Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction
Sun, K., de Pablo, Y., Vincent, F., & Shah, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05616.x · Cited by 124
Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: On defects in the cytochrome c oxidase complex and aldehyde detoxification
Ohta, S., & Ohsawa, I. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9208 · Cited by 121
Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice.
Desrumaux, C., Risold, P.-Y., Schroeder, H., Deckert, V., Masson, D., Athias, A., Laplanche, H., Le Guern, N., Blache, D., Jiang, X.-C., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2400fje · Cited by 122
ABCG2 reduces ROS‐mediated toxicity and inflammation: a potential role in Alzheimer’s disease
Shen, S., Callaghan, D., Juźwik, C. A., Xiong, H., Huang, P., & Zhang, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06887.x · Cited by 122
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
Cenini, G., Dowling, A. L. S., Beckett, T. L., Barone, E., Mancuso, C., Murphy, M. P., LeVine, H., Lott, I. T., Schmitt, F. A., Butterfield, D. A., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.001 · Cited by 126
Chitotriosidase: the yin and yang
Malaguarnera, L. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6269-2 · Cited by 122
Disparate patterns of age‐related changes in lipid peroxidation in long‐lived naked mole‐rats and shorter‐lived mice
Andziak, B., & Buffenstein, R. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00246.x · Cited by 121
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
Praticò, D., Rokach, J., Lawson, J., & FitzGerald, G. A. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.012 · Cited by 120
Self-citation
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
Santos, R. X., Correia, S. C., Wang, X., Perry, G. L., Smith, M. A., Moreira, P. I., & Zhu, X. (2010) · Europe PMC (PubMed Central) · Cited by 120
Microglial P2X7receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease
Lee, H. G., Won, S. M., Gwag, B. J., & Lee, Y. B. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.1.001 · Cited by 122
New Insights in the Amyloid-Beta Interaction with Mitochondria
Spuch, C., Ortolano, S., & Fernández-Balbuena, C. N. (2012) · Journal of Aging Research · doi:10.1155/2012/324968 · Cited by 121
Recent advances in the biochemistry and clinical relevance of the isoprostane pathway
Musiek, E. S., Yin, H., Milne, G. L., & Morrow, J. D. (2005) · Lipids · doi:10.1007/s11745-005-1460-7 · Cited by 117
Consensus Paper of the WFSBP Task Force on Biological Markers of Dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia
Wiltfang, J., Lewczuk, P., Riederer, P. F., Grünblatt, E., Hock, C., Scheltens, P., Hampel, H. J., Vanderstichele, H., Iqbal, K., Galasko, D. R., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029786 · Cited by 120
P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?
Szybińska, A., & Leśniak, W. (2017) · Aging and Disease · doi:10.14336/ad.2016.1120 · Cited by 118
Mitochondrial iron metabolism and neurodegenerative diseases
Cheng, R., Dhorajia, V. V., Kim, J., & Kim, Y. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.11.003 · Cited by 121
Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease
Wilkinson, B. L., Cramer, P. E., Varvel, N. H., Reed-Geaghan, E. G., Jiang, Q., Szabo, A., Herrup, K., Lamb, B. T., & Landreth, G. E. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.06.014 · Cited by 118
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
Ma, Q., Teter, B., Ubeda, O. J., Morihara, T., Dhoot, D. S., Nyby, M. D., Tuck, M. L., Frautschy, S. A., & Cole, G. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3593-07.2007 · Cited by 115
Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease
Fernández‐Vizarra, P., Fernández, A. P., Castro‐Blanco, S., Encinas, J. M., Serrano, J., Bentura, M. L., Muñoz, P., Martínez‐Murillo, R., & Rodrigo, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.10.010 · Cited by 115
Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS
Drechsel, D. A., Estévez, Á. G., Barbeito, L., & Beckman, J. S. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9322-y · Cited by 117
Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials
Quinn, J. F., Kulhanek, D. J., Nowlin, J., Jones, R. E., Praticò, D., Rokach, J., & Stackman, R. W. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.023 · Cited by 114
Self-citation
iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease
Martin, B., Brenneman, R., Becker, K. G., Guček, M., Cole, R. N., & Maudsley, S. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002750 · Cited by 113
F 2 -Isoprostanes in Alzheimer and Other Neurodegenerative Diseases
Montine, T. J., Montine, K. S., McMahan, W., Markesbery, W. R., Quinn, J. F., & Morrow, J. D. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.269 · Cited by 113
Triterpenoid CDDO‐methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer’s disease
Dumont, M., Wille, E. J., Calingasan, N. Y., Tampellini, D., Williams, C. R., Gouras, G. K., Liby, K. T., Sporn, M. B., Beal, M. F., & Lin, M. T. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05970.x · Cited by 112
Oxidative stress in Alzheimer's disease
Gibson, G. E., & Huang, H. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.017 · Cited by 110
Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: A paradigm for multifactorial neurodegenerative diseases?
Galea, E., Launay, N., Portero-Otin, M., Ruiz, M., Pamplona, R., Aubourg, P., Ferrer, I., & Pujol, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.005 · Cited by 108
Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers
Yoshida, Y., Yoshikawa, A., Kinumi, T., Ogawa, Y., Saito, Y., Ohara, K., Yamamoto, H., Imai, Y., & Niki, E. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.012 · Cited by 109
Peoniflorin attentuates Aβ(1–42)-mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats
Zhong, S., Ge, Q.-H., Li, Q., Qu, R., & Ma, S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.01.027 · Cited by 108
Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2
Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 109
Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress
Goguadze, N., Zhuravliova, E., Morin, D., Mikeladze, D., & Maurice, T. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9838-2 · Cited by 108
Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins
Murray, I. V. J., Liu, L., Komatsu, H., Uryu, K., Xiao, G., Lawson, J. A., & Axelsen, P. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608589200 · Cited by 106
Self-citation
Mitochondrial Dynamics in Alzheimerʼs Disease
Bonda, D., Wang, X., Perry, G. L., Smith, M. A., & Zhu, X. (2010) · Drugs & Aging · doi:10.2165/11532140-000000000-00000 · Cited by 106
2,4 Dinitrophenol as Medicine
Geisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104
Redox Signaling in Neurotransmission and Cognition During Aging
Kumar, A., Yegla, B., & Foster, T. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7111 · Cited by 106
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 112
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models
Sonnen, J. A., Breitner, J. C. S., Lovell, M. A., Markesbery, W. R., Quinn, J. F., & Montine, T. J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.022 · Cited by 107
Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's disease
Jo, D., Arumugam, T. V., Woo, H., Park, J. S., Tang, S., Mughal, M. R., Hyun, D., Park, J.-H., Choi, Y., Gwon, A., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.003 · Cited by 105
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia
Rosa, M. D., dell'Ombra, N., Zambito, A. M., Malaguarnera, M., Nicoletti, F., & Malaguarnera, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04780.x · Cited by 102
Formation of aberrant phosphotau fibrillar polymers in neural cultured cells
Pérez, M., Hernández, F., Gómez‐Ramos, A., Smith, M. A., Perry, G. L., & Ávila, J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02794.x · Cited by 103
Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
Quinn, J. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00037-7 · Cited by 102
Amyloid β Oligomers Increase ER-Mitochondria Ca2+ Cross Talk in Young Hippocampal Neurons and Exacerbate Aging-Induced Intracellular Ca2+ Remodeling
Calvo-Rodríguez, M., Hernando-Pérez, E., Núñez, L., & Villalobos, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00022 · Cited by 103
Oxidative stress in Alzheimer’s Disease: Implications for Prevention and Therapy
Behl, C. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_3 · Cited by 100
Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders
Assisi, A., Banzi, R., Buonocore, C., Capasso, F., Muzio, V., Michelacci, F., Renzo, D., Tafuri, G., Trotta, F., Vitocolonna, M., et al. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224790.98534.11 · Cited by 101
DNP, mitochondrial uncoupling, and neuroprotection: A little dab'll do ya
Geisler, J. G., Marosi, K., Halpern, J., & Mattson, M. P. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.001 · Cited by 104
Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution
Ciccotosto, G. D., Tew, D. J., Curtain, C. C., Smith, D., Carrington, D., Masters, C. L., Bush, A. I., Cherny, R. A., Cappai, R., & Barnham, K. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406465200 · Cited by 101
Oxidative lipid modification of nicastrin enhances amyloidogenic γ‐secretase activity in Alzheimer’s disease
Gwon, A., Park, J., Arumugam, T. V., Kwon, Y., Chan, S. L., Kim, S.-H., Baik, S., Yang, S.-H., Yun, Y., Choi, Y., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00817.x · Cited by 101
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease
Mosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., McHugh, P., & Swerdlow, R. H. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110866 · Cited by 97
Signal Transduction Cascades Associated with Oxidative Stress in Alzheimer's Disease
Petersen, R. B., Nunomura, A., Lee, H., Casadesús, G., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11202 · Cited by 101
Oxidative damage and the pathogenesis of menopause related disturbances and diseases
Cervellati, C., & Bergamini, C. M. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0807 · Cited by 101
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 97
Cilostazol prevents amyloid β peptide25‐35‐induced memory impairment and oxidative stress in mice
Hiramatsu, M., Takiguchi, O., Nishiyama, A., & Mori, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01014.x · Cited by 96
Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease
Reddy, P. H., Mańczak, M., Yin, X., & Reddy, A. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170988 · Cited by 97
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 103
Estrogen Regulation of Mitochondrial Bioenergetics
Yao, J., & Brinton, R. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00010-6 · Cited by 103
Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice
Schüssel, K., Frey, C., Jourdan, C., Keil, U., Weber, C. C., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.041 · Cited by 94
Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: Involvement of oxidative stress and cholinergic dysfunction
Zhang, W., Bai, M., Ye, X., Hao, J., Liu, L., Mao, N., Su, C., Miao, J., & Li, Z. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.023 · Cited by 97
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies
Mistur, R. L., Mosconi, L., Santi, S. D., Guzman, M., Li, Y., Tsui, W., & de Leon, M. J. (2009) · Journal of Clinical Neurology · doi:10.3988/jcn.2009.5.4.153 · Cited by 101
Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1–42) rat model of Alzheimer’s disease
Hriţcu, L., Noumedem, J. A. K., Cioancă, O., Hăncianu, M., Postu, P. A., & Mihăşan, M. (2015) · Behavioral and Brain Functions · doi:10.1186/s12993-015-0059-7 · Cited by 94
Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
Feng, S.-T., Wang, Z.-Z., Yuan, Y.-H., Sun, H.-M., Chen, N.-H., & Zhang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104336 · Cited by 96
Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice
Min, L., Kobayashi, Y., Mogi, M., Tsukuda, K., Yamada, A., Yamauchi, K., Abe, F., Iwanami, J., Xiao, J., & Horiuchi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171515 · Cited by 92
Pinus halepensis essential oil attenuates the toxic Alzheimer’s amyloid beta (1-42)-induced memory impairment and oxidative stress in the rat hippocampus
Postu, P. A., Sadiki, F. Z., Idrissi, M. E., Cioancă, O., Trifan, A., Hăncianu, M., & Hriţcu, L. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108673 · Cited by 92
Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of α-, β- and γ-secretase expression
Quiroz‐Baez, R., Rojas, E., & Arias, C. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.06.012 · Cited by 93
Long-Term Intermittent Hypoxia
Veasey, S. C., Zhan, G., Fenik, P., & Pratico, D. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-261oc · Cited by 91
Self-citation
Retinoids as potential targets for Alzheimer's disease
Sodhi, R. K., & Singh, N. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.016 · Cited by 94
Impaired Rapid Eye Movement Sleep in the Tg2576 APP Murine Model of Alzheimer's Disease with Injury to Pedunculopontine Cholinergic Neurons
Zhang, B., Veasey, S. C., Wood, M. A., Leng, L. Z., Kaminski, C., Leight, S., Abel, T. G., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61223-0 · Cited by 95
Self-citation
Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Stanga, S., Caretto, A., Boido, M., & Vercelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103719 · Cited by 90
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
O’Neal-Moffitt, G., Delic, V., Bradshaw, P. C., & Olcese, J. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0027-6 · Cited by 91
Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis.
Yao, Y., Chinnici, C. M., Tang, H., Trojanowski, J. Q., Lee, V. M. ‐., & Praticò, D. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-21 · Cited by 91
Self-citation
Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling
Kang, S., Kim, C. H., Jung, H., Kim, E., Song, H., & Lee, J. E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.029 · Cited by 92
Polyunsaturated Fatty Acid Deuteration against Neurodegeneration
Shchepinov, M. S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.010 · Cited by 86
Acceleration of brain amyloidosis in an Alzheimer’s disease mouse model by a folate, vitamin B6 and B12-deficient diet
Zhuo, J., & Praticò, D. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.12.005 · Cited by 90
Self-citation
Interventions for age-related diseases: Shifting the paradigm
Figueira, I., Fernandes, A. M. A., Mladenović, A., Lopez-Contreras, A. J., Henriques, C. M., Selman, C., Ferreiro, E. B., Gonos, E. S., Trejo, J. L., Misra, J., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.009 · Cited by 92
Akkermansia muciniphila induces mitochondrial calcium overload and α -synuclein aggregation in an enteroendocrine cell line
Neto, D. P. A., Bosque, B. P., de Godoy, J. V. P., Rodrigues, P. V., Meneses, D. D., Tostes, K., Tonoli, C. C. C., Carvalho, H. F., González-Billault, C. E., & Fonseca, M. D. C. (2022) · iScience · doi:10.1016/j.isci.2022.103908 · Cited by 90
Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
Zhao, X., Tian, Z., Sun, M., & Dong, D. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01565-0 · Cited by 94
Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes
Gibson, G. E., Hirsch, J. A., Cirio, R. T., Jordan, B. D., Fonzetti, P., & Elder, J. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.09.001 · Cited by 90
Characterization of Aldh2 -/- mice as an age-related model of cognitive impairment and Alzheimer’s disease
D’Souza, Y., Elharram, A., Soon-Shiong, R., Andrew, R. D., & Bennett, B. M. (2015) · Molecular Brain · doi:10.1186/s13041-015-0117-y · Cited by 87
Blood markers of oxidative stress in A lzheimer's disease
Skoumalová, A., & Hort, J. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01585.x · Cited by 93
Mitochondria and Antioxidant Targeted Therapeutic Strategies for Alzheimer's Disease
Dumont, M., Lin, M. T. S., & Beal, M. F. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100507 · Cited by 85
Alzheimer’s disease: as it was in the beginning
Kozlov, S. O., Afonin, A. М., Evsyukov, I., & Бондаренко, А. Б. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0006 · Cited by 87
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
Shen, S., Liao, Q., Wong, Y. K., Chen, X., Yang, C., Xu, C., Sun, J., & Wang, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66871 · Cited by 91
Lipid Peroxidation Drives Liquid–Liquid Phase Separation and Disrupts Raft Protein Partitioning in Biological Membranes
Balakrishnan, M., & Kenworthy, A. K. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c10132 · Cited by 90
A chronic Alzheimer’s model evoked by mitochondrial poison sodium azide for pharmacological investigations
Szabados, T., Dul, C., Majtényi, K., Hargitai, J., Pénzes, Z., & Urbanics, R. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.016 · Cited by 84
Oxygen metabolism abnormality and Alzheimer's disease: An update
Liu, G., Yang, C., Wang, X., Chen, X., Wang, Y., & Le, W. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102955 · Cited by 87
Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease
Wu, Z., Ciallella, J. R., Flood, D. G., O’Kane, T. M., Bozyczko‐Coyne, D., & Savage, M. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.010 · Cited by 84
Longitudinal CSF isoprostane and MRI atrophy in the progression to AD
de Leon, M. J., Mosconi, L., Li, J., Santi, S. D., Yao, Y., Tsui, W.-H., Pirraglia, E., Rich, K. E., Javier, E., Bryś, M., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0610-z · Cited by 82
Self-citation
Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein
White, A. R., Multhaup, G., Galatis, D., McKinstry, W. J., Parker, M. W., Pipkorn, R., Beyreuther, K. T., Masters, C. L., & Cappai, R. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00365.2002 · Cited by 82
Copper reduction by copper binding proteins and its relation to neurodegenerative diseases
Opazo, C., Barría, M. I., Ruiz, F. H., & Inestrosa, N. C. (2003) · BioMetals · doi:10.1023/a:1020795422185 · Cited by 83
Promotion of Amyloid β Protein Misfolding and Fibrillogenesis by a Lipid Oxidation Product
Liu, L., Komatsu, H., Murray, I. V. J., & Axelsen, P. H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.057 · Cited by 81
Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age
Abdul, H. M., Rukhsana Sultana, A., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.012 · Cited by 81
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 82
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease
Nunomura, A., Tamaoki, T., Tanaka, K., Motohashi, N., Nakamura, M., Hayashi, T., Yamaguchi, H., Shimohama, S., Lee, H., Zhu, X., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.012 · Cited by 82
Different phenotypes of microglia in animal models of Alzheimer disease
Wei, Y., & Li, X. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00300-0 · Cited by 86
Mitochondrial biology in Alzheimer’s disease pathogenesis
Galindo, M. F., Ikuta, I., Zhu, X., Casadesús, G., & Jordán, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06814.x · Cited by 79
Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders
Yang, S., He, X., Isaacs, C. E., Dobkin, C., Miller, D. L., & Philipp, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.001 · Cited by 85
Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease
Wang, C., Liu, M.-Y., Wang, F., Wei, M., Wang, S., Wu, C., & Yang, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.03.010 · Cited by 80
Dual-Channel Imaging of Amyloid-β Plaques and Peroxynitrite To Illuminate Their Correlations in Alzheimer’s Disease Using a Unimolecular Two-Photon Fluorescent Probe
Xie, X., Liu, G., Niu, Y., Xu, C., Li, Y., Zhang, J., Jiao, X., Wang, X., & Tang, B. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03334 · Cited by 77
Melatonin attenuates isoproterenol‐induced protein kinase A overactivation and tau hyperphosphorylation in rat brain
Wang, D., Ling, Z.-Q., Cao, F., Zhu, L., & Wang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00130.x · Cited by 77
A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders
Thapliyal, S., Singh, T., Handu, S. S., Bisht, M., Kumari, P., Arya, P., Srivastava, P., & Ravi, G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03257-6 · Cited by 77
Oxidative challenge in Alzheimer's disease: state of knowledge and future needs
Cervellati, C., Wood, P. L., Romani, A., Valacchi, G., Squerzanti, M., Sanz, J. M., Ortolani, B., & Zuliani, G. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2015-000017 · Cited by 75
Resveratrol Oligomers from Vitis amurensis Attenuate .BETA.-Amyloid-Induced Oxidative Stress in PC12 Cells
Jang, M. H., Piao, X. L., Kim, H. Y., Cho, E., Baek, S. H., Kwon, S. W., & Park, J. H. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.1130 · Cited by 75
Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells
Montilla-López, P., Muñoz-Águeda, M. C., Feijóo, M., Muñoz-Castañeda, J. R., Bujalance, I., & Túnez‐Fiñana, I. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02151-9 · Cited by 76

Authors: Praticò, D., Uryu, K., Leight, S., Trojanoswki, J. Q., & Lee, V. M.-Y.
Affiliations: University of Pennsylvania (US)
ORCID: Praticò, Domenico
Uryu, Kunihiro
Lee, Virginia M.-Y.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2001-06-15
Volume: 21
Issue: 12
Pages: 4183-4187
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.21-12-04183.2001
PMC: PMC6762743
OpenAlex: W1954454186
Cited by: 777
References: 24
Citations by year: 2026: 4 · 2025: 15 · 2024: 17 · 2023: 29 · 2022: 19 · 2021: 32 · 2020: 23 · 2019: 27 · 2018: 16 · 2017: 24 · 2016: 24 · 2015: 28 · 2014: 32 · 2013: 37 · 2012: 48
FWCI: 22.76
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 183 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: American Heart Association
National Institutes of Health (AG-11542)
National Institute on Aging (P01AG011542, AG 11542)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: lipid peroxidation, isoprostanes, amyloid-beta, amyloid plaques, Alzheimer's disease, Tg2576 mice, oxidative stress, Aβ40, amyloid-beta 42, brain oxidative damage, pathogenesis
MeSH terms: Aging, Alzheimer Disease, Amyloidosis, Animals, Brain, Cerebellum, Cerebral Cortex, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Hippocampus, Male, Mice, Transgenic, Peptide Fragments, Lipid Peroxidation, Dinoprost, Amyloid beta-Peptides, Mice, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks